Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Heart in Systemic Disease

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

A wide variety of systemic diseases may affect the heart by a number of different mechanisms, including increasing demands on the heart, causing arrhythmias, affecting the structure of the heart or promoting cardiovascular disease and therefore ischaemic heart disease. Common cardiac associations with systemic disease include:

Heart failure

Heart failure may be caused or precipitated by any condition that puts a greater demand on the heart, e.g. fever, severe anaemia, thyrotoxicosis and pregnancy.

Atherosclerosis

Hypertension

Any cause of secondary hypertension, such as renal disease (e.g. glomerulonephritis, polyarteritis nodosa, systemic sclerosis, chronic pyelonephritis, or polycystic kidneys), or endocrine disease (e.g. Cushing's syndrome, Conn's syndrome, phaeochromocytoma, acromegaly, hyperparathyroidism) may cause hypertensive heart disease, which may lead to left ventricular hypertrophy.

Lung disease

Disease of the lungs can also lead to right ventricular hypertrophy and strain.

Rheumatic fever

Rheumatic fever is now very uncommon in Western Europe, although it is still seen in other parts of the world, especially Africa.

  • Rheumatic fever may cause disease of the mitral valve and/or the aortic valve. This is usually mitral stenosis or aortic stenosis but mitral regurgitation or aortic regurgitation may occur alone or in combination.
  • Acute rheumatic fever is also associated with myocarditis, which can be severe. A soft, rumbling, mid-diastolic murmur, called the Carey Coombs' murmur, may be heard during active disease. Severe disease is associated with a greater risk of recurrence.

Other causes of valvular heart disease

As rheumatic fever appears to be confined to history, at least in the UK, other causes of disease of heart valves take importance. Many are congenital heart disease.

  • Ankylosing spondylitis may be associated with aortic regurgitation.
  • Incompetent valves, including mitral valve prolapse may occur with a number of the hypermobility syndromes, including Ehlers-Danlos syndrome, Marfan's syndrome, Down's syndrome and joint hypermobility syndrome.
  • Marfan's syndrome may cause aortic regurgitation and even aortic aneurysm at the root.
  • Another cause of aneurysm of the proximal aorta with aortic regurgitation is tertiary syphilis.
  • Heart valves may be affected in many systemic autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), antiphospholipid antibody syndrome, the seronegative spondyloarthropathies, the systemic vasculitides, and scleroderma.3

Any damage or abnormality of the heart or valves makes them susceptible to subacute bacterial endocarditis. Acute bacterial endocarditis can occur when drug addicts inject themselves with heavily infected material.

Pericardial disease

Cardiomyopathy

Cardiomyopathy is discussed much more fully in the separate article Cardiomyopathies.. They may be primary or due to other disease. Many systemic diseases may cause cardiomyopathy, including:

  • Sarcoidosis.
  • Metabolic: diabetes, amyloidosis, Wilson's disease, haemochromatosis, glycogen storage diseases.
  • Drugs and poisons:
    • Alcohol probably requires around 7 or 8 units a day for at least 5 years.4 However, it is probably an underdiagnosed cause and may represent 30% of dilated cardiomyopathy.5 Women are susceptible at a lower dose than men.6 High consumption of alcohol also leads to hypertension.
    • Many other substances have been implicated.7 Examples include cocaine, amfetamines, chemotherapy for malignancy.
  • Cardiomyopathy may occur in patients on long-term dialysis.
  • Endocrine disease: acromegaly, phaeochromocytoma, diabetes mellitus (maternal diabetes can also have an adverse effect on the developing fetal heart),8 hyperthyroidism, hypothyroidism.
  • Connective tissue disorders: systemic sclerosis (may cause myocarditis or pericardial effusion), rheumatoid arthritis (can cause pericardial effusion, valvulitis and myocardial fibrosis), systemic lupus erythematosus (is associated with pericarditis, hypertension, an increased risk of coronary heart disease and Libman-Sacks endocarditis).
  • Infections: acute viral infection (especially Coxsackie B), South American trypanosomiasis (Chagas' disease), hepatitis B, HIV infection.
  • Nutritional: malnutrition, vitamin B1 deficiency, obesity.
  • Myopathies: Duchenne's muscular dystrophy, Becker's muscular dystrophy.

Malignant disease

  • Metastatic spread of malignancy to the heart is far more common than primary cardiac tumours.9 The most common clinical presentation is from pericardial effusion, tachyarrhythmias, atrioventricular block, and congestive heart failure.
  • Tumours most likely to metastasise to the heart are malignant melanoma, leukaemia, malignant germ cell tumours and malignant thymoma.
  • Although carcinoma of the lung and breast do not often metastasise to the heart, because of the very high numbers, they account for the greatest numbers of cardiac metastases.
  • Carcinoma of the lung can also cause atrial fibrillation in the absence of metastatic spread to the heart.

Central nervous system

Renal disease

Abnormalities of renal function may affect the heart in a number of ways:

Assessment

If there is any suspicion that the heart may be involved in systemic disease, this needs to be investigated or it may become apparent on other investigations. In addition to any other investigation for the suspected underlying disease:


Document references

  1. Olijhoek JK, van der Graaf Y, Banga JD, et al; The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004 Feb;25(4):342-8. [abstract]
  2. Kremers HM, Gabriel SE; Rheumatoid arthritis and the heart. Curr Heart Fail Rep. 2006 Jun;3(2):57-63. [abstract]
  3. Maksimowicz-McKinnon K, Mandell BF; Understanding valvular heart disease in patients with systemic autoimmune diseases. Cleve Clin J Med. 2004 Nov;71(11):881-5. [abstract]
  4. Piano MR; Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest. 2002 May;121(5):1638-50. [abstract]
  5. Lee WK, Regan TJ; Alcoholic cardiomyopathy: is it dose-dependent? Congest Heart Fail. 2002 Nov-Dec;8(6):303-6. [abstract]
  6. Fernandez-Sola J, Nicolas-Arfelis JM; Gender differences in alcoholic cardiomyopathy. J Gend Specif Med. 2002 Jan-Feb;5(1):41-7. [abstract]
  7. Shik J, Parfrey PS; The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens. 2005 Nov;14(6):550-7. [abstract]
  8. Hornberger LK; Maternal diabetes and the fetal heart. Heart. 2006 Aug;92(8):1019-21. Epub 2006 May 12. [abstract]
  9. Butany J, Nair V, Naseemuddin A, et al; Cardiac tumours: diagnosis and management. Lancet Oncol. 2005 Apr;6(4):219-28. [abstract]
© EMIS 2011Author: Dr Colin TidyReviewer: Dr Hayley Willacy
Document ID: 3897Document Version: 22Last Reviewed: 7 Aug 2011
Provide feedback